Trial Outcomes & Findings for Advanced Metagenomic Analysis of Human Colonic Microbiota in Patients With Chronic GI Disorders (NCT NCT01099111)
NCT ID: NCT01099111
Last Updated: 2014-05-22
Results Overview
The entire mucosal microbial community were profiled using high-throughput DNA sequencing and microarray technology. The microarray approach is based on 16S rRNA gene targeted oligonucleotide allowing the rapid detection of thousands of DNA sequences simultaneously and thus constitutes an ideal tool to generate a comprehensive and holistic view of the gut microbial community in all participants of all study arms. Then they will be analysed between different colonic segments in each participant, pooled results of participants in each of the 5 arms will be compared to the measurable outcomes of other arms in general.
COMPLETED
225 participants
1 - 2 weeks
2014-05-22
Participant Flow
Recruitment was conducted at KFMC (tertiary care medical center), starting 1/7/2010 and completed 29/9/2012. Demographic and clinical data were collected for all, together with performance of colonoscopy at entry and collection of samples as specified.
We were able to recruit the desired number for normal, IBS and UC groups. However, in view of strict inclusion and exclusion criteria, only 46 were recruited for CD and only 29 were recruited for CRC. Moreover, DNA extraction was not sufficient for some subjects at all groups that indicate replacing them with other patients.
Participant milestones
| Measure |
Irritable Bowel Syndrome
50 subjects that exactly meet our inclusion \& exclusion criteria were recruited. Demographic and clinical data were entered for each during the introduction to the study and verifying acceptance to participate. Then after unified bowel preparation protocol, a full Colonoscopy was performed after signing the consent, during which mucosal washing samples were collected from the unified 4 colonic segment sites, as specified in methodology.
Recruitment were completed on 08/05/2011, however, in view of insufficient DNA extraction of 5 subjects they have been replaced (on 28/07/2012) with other 5 subjects following exactly the same protocol.
Now, all are identified as sufficient DNA extraction and had been enrolled into a comprehensive analysis of the gastrointestinal tract microbiota and its contribution on gut homeostasis by using state of the art metagenomics technology.
|
Ulcerative Colitis
50 subjects that exactly meet our inclusion \& exclusion criteria were recruited. Demographic and clinical data were entered for each during the introduction to the study and verifying acceptance to participate. Then after unified bowel preparation protocol, a full Colonoscopy was performed after signing the consent, during which mucosal washing samples were collected from the unified 4 colonic segment sites, as specified in methodology.
Recruitment were completed on 05/06/2012, however, in view of insufficient DNA extraction of 3 subjects they have been replaced on 16/09/2012 with other 3 subjects following exactly the same protocol.
Now, all are identified as sufficient DNA extraction and had been enrolled into a comprehensive analysis of the gastrointestinal tract microbiota and its contribution on gut homeostasis by using state of the art metagenomics technology.
|
Crohn's Disease
46 subjects that exactly meet our inclusion \& exclusion criteria were recruited. Demographic and clinical data were entered for each during the introduction to the study and verifying acceptance to participate. Then after unified bowel preparation protocol, a full Colonoscopy was performed after signing the consent, during which mucosal washing samples were collected from the unified 4 colonic segment sites, as specified in methodology.
Recruitment were completed on 27/05/2012, however, in view of insufficient DNA extraction of 2 subjects they have been replaced on 05/09/2012 with other 2 subjects following exactly the same protocol.
Now, all are identified as sufficient DNA extraction and had been enrolled into a comprehensive analysis of the gastrointestinal tract microbiota and its contribution on gut homeostasis by using state of the art metagenomics technology.
|
Colo Rectal Cancer
29 subjects that exactly meet our inclusion \& exclusion criteria were recruited. Demographic and clinical data were entered for each during the introduction to the study and verifying acceptance to participate. Then after unified bowel preparation protocol, a full Colonoscopy was performed after signing the consent, during which mucosal washing samples were collected from the unified 4 colonic segment sites, as specified in methodology.
Recruitment were completed on 28/05/2012, and all have been identified as sufficient DNA extraction.
Now, all are identified as sufficient DNA extraction and had been enrolled into a comprehensive analysis of the gastrointestinal tract microbiota and its contribution on gut homeostasis by using state of the art metagenomics technology.
|
Control: Normal Subjects
50 subjects that exactly meet our inclusion \& exclusion criteria were recruited. Demographic and clinical data were entered for each during the introduction to the study and verifying acceptance to participate. Then after unified bowel preparation protocol, a full Colonoscopy was performed after signing the consent, during which mucosal washing samples were collected from the unified 4 colonic segment sites, as specified in methodology.
Recruitment were completed on 22/12/2010, however, in view of insufficient DNA extraction of 6 subjects they have been replaced on 19/09/2012 with other 6 subjects following exactly the same protocol.
Now, all are identified as sufficient DNA extraction and had been enrolled into a comprehensive analysis of the gastrointestinal tract microbiota and its contribution on gut homeostasis by using state of the art metagenomics technology.
|
|---|---|---|---|---|---|
|
Overall Study
STARTED
|
50
|
50
|
46
|
29
|
50
|
|
Overall Study
COMPLETED
|
50
|
50
|
46
|
29
|
50
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
0
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Advanced Metagenomic Analysis of Human Colonic Microbiota in Patients With Chronic GI Disorders
Baseline characteristics by cohort
| Measure |
Irritable Bowel Syndrome
n=50 Participants
50 subjects that exactly meet our inclusion \& exclusion criteria were recruited. Demographic and clinical data were entered for each during the introduction to the study and verifying acceptance to participate. Then after unified bowel preparation protocol, a full Colonoscopy was performed after signing the consent, during which mucosal washing samples were collected from the unified 4 colonic segment sites, as specified in methodology.
Recruitment were completed on 08/05/2011, however, in view of insufficient DNA extraction of 5 subjects they have been replaced (on 28/07/2012) with other 5 subjects following exactly the same protocol.
Now, all are identified as sufficient DNA extraction and had been enrolled into a comprehensive analysis of the gastrointestinal tract microbiota and its contribution on gut homeostasis by using state of the art metagenomics technology.
|
Ulcerative Colitis
n=50 Participants
50 subjects that exactly meet our inclusion \& exclusion criteria were recruited. Demographic and clinical data were entered for each during the introduction to the study and verifying acceptance to participate. Then after unified bowel preparation protocol, a full Colonoscopy was performed after signing the consent, during which mucosal washing samples were collected from the unified 4 colonic segment sites, as specified in methodology.
Recruitment were completed on 05/06/2012, however, in view of insufficient DNA extraction of 3 subjects they have been replaced on 16/09/2012 with other 3 subjects following exactly the same protocol.
Now, all are identified as sufficient DNA extraction and had been enrolled into a comprehensive analysis of the gastrointestinal tract microbiota and its contribution on gut homeostasis by using state of the art metagenomics technology.
|
Crohn's Disease
n=46 Participants
46 subjects that exactly meet our inclusion \& exclusion criteria were recruited. Demographic and clinical data were entered for each during the introduction to the study and verifying acceptance to participate. Then after unified bowel preparation protocol, a full Colonoscopy was performed after signing the consent, during which mucosal washing samples were collected from the unified 4 colonic segment sites, as specified in methodology.
Recruitment were completed on 27/05/2012, however, in view of insufficient DNA extraction of 2 subjects they have been replaced on 05/09/2012 with other 2 subjects following exactly the same protocol.
Now, all are identified as sufficient DNA extraction and had been enrolled into a comprehensive analysis of the gastrointestinal tract microbiota and its contribution on gut homeostasis by using state of the art metagenomics technology.
|
Colo Rectal Cancer
n=29 Participants
29 subjects that exactly meet our inclusion \& exclusion criteria were recruited. Demographic and clinical data were entered for each during the introduction to the study and verifying acceptance to participate. Then after unified bowel preparation protocol, a full Colonoscopy was performed after signing the consent, during which mucosal washing samples were collected from the unified 4 colonic segment sites, as specified in methodology.
Recruitment were completed on 28/05/2012, and all have been identified as sufficient DNA extraction.
Now, all are identified as sufficient DNA extraction and had been enrolled into a comprehensive analysis of the gastrointestinal tract microbiota and its contribution on gut homeostasis by using state of the art metagenomics technology.
|
Control: Normal Subjects
n=50 Participants
50 subjects that exactly meet our inclusion \& exclusion criteria were recruited. Demographic and clinical data were entered for each during the introduction to the study and verifying acceptance to participate. Then after unified bowel preparation protocol, a full Colonoscopy was performed after signing the consent, during which mucosal washing samples were collected from the unified 4 colonic segment sites, as specified in methodology.
Recruitment were completed on 22/12/2010, however, in view of insufficient DNA extraction of 6 subjects they have been replaced on 19/09/2012 with other 6 subjects following exactly the same protocol.
Now, all are identified as sufficient DNA extraction and had been enrolled into a comprehensive analysis of the gastrointestinal tract microbiota and its contribution on gut homeostasis by using state of the art metagenomics technology.
|
Total
n=225 Participants
Total of all reporting groups
|
|---|---|---|---|---|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=93 Participants
|
4 Participants
n=4 Participants
|
11 Participants
n=27 Participants
|
0 Participants
n=483 Participants
|
0 Participants
n=36 Participants
|
15 Participants
n=10 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
45 Participants
n=93 Participants
|
45 Participants
n=4 Participants
|
34 Participants
n=27 Participants
|
23 Participants
n=483 Participants
|
41 Participants
n=36 Participants
|
188 Participants
n=10 Participants
|
|
Age, Categorical
>=65 years
|
5 Participants
n=93 Participants
|
1 Participants
n=4 Participants
|
1 Participants
n=27 Participants
|
6 Participants
n=483 Participants
|
9 Participants
n=36 Participants
|
22 Participants
n=10 Participants
|
|
Age, Continuous
|
43.93 years
STANDARD_DEVIATION 14.505 • n=93 Participants
|
34.42 years
STANDARD_DEVIATION 12.586 • n=4 Participants
|
25.19 years
STANDARD_DEVIATION 10.672 • n=27 Participants
|
55.03 years
STANDARD_DEVIATION 10.137 • n=483 Participants
|
53.58 years
STANDARD_DEVIATION 12.747 • n=36 Participants
|
42.43 years
STANDARD_DEVIATION 12.71 • n=10 Participants
|
|
Sex: Female, Male
Female
|
31 Participants
n=93 Participants
|
34 Participants
n=4 Participants
|
24 Participants
n=27 Participants
|
14 Participants
n=483 Participants
|
32 Participants
n=36 Participants
|
135 Participants
n=10 Participants
|
|
Sex: Female, Male
Male
|
19 Participants
n=93 Participants
|
16 Participants
n=4 Participants
|
22 Participants
n=27 Participants
|
15 Participants
n=483 Participants
|
18 Participants
n=36 Participants
|
90 Participants
n=10 Participants
|
|
Region of Enrollment
Saudi Arabia
|
50 participants
n=93 Participants
|
50 participants
n=4 Participants
|
46 participants
n=27 Participants
|
29 participants
n=483 Participants
|
50 participants
n=36 Participants
|
225 participants
n=10 Participants
|
PRIMARY outcome
Timeframe: 1 - 2 weeksPopulation: Each participant colonic mucosal microbiota populations pattern were analysed, and then compared to control to look for specific enrichments. If the DNA extract was not enough for sequencing, then the participant sample was excluded, however analysis calculation was based on all enrolled participants. The number analyzed here represent all enrolled
The entire mucosal microbial community were profiled using high-throughput DNA sequencing and microarray technology. The microarray approach is based on 16S rRNA gene targeted oligonucleotide allowing the rapid detection of thousands of DNA sequences simultaneously and thus constitutes an ideal tool to generate a comprehensive and holistic view of the gut microbial community in all participants of all study arms. Then they will be analysed between different colonic segments in each participant, pooled results of participants in each of the 5 arms will be compared to the measurable outcomes of other arms in general.
Outcome measures
| Measure |
Irritable Bowel Syndrome
n=48 Participants
50 subjects that exactly meet our inclusion \& exclusion criteria were recruited. Demographic and clinical data were entered for each during the introduction to the study and verifying acceptance to participate. Then after unified bowel preparation protocol, a full Colonoscopy was performed after signing the consent, during which mucosal washing samples were collected from the unified 4 colonic segment sites, as specified in methodology.
Recruitment were completed on 08/05/2011, however, in view of insufficient DNA extraction of 5 subjects they have been replaced (on 28/07/2012) with other 5 subjects following exactly the same protocol.
Now, all are identified as sufficient DNA extraction and had been enrolled into a comprehensive analysis of the gastrointestinal tract microbiota and its contribution on gut homeostasis by using state of the art metagenomics technology.
|
Ulcerative Colitis
n=48 Participants
50 subjects that exactly meet our inclusion \& exclusion criteria were recruited. Demographic and clinical data were entered for each during the introduction to the study and verifying acceptance to participate. Then after unified bowel preparation protocol, a full Colonoscopy was performed after signing the consent, during which mucosal washing samples were collected from the unified 4 colonic segment sites, as specified in methodology.
Recruitment were completed on 05/06/2012, however, in view of insufficient DNA extraction of 3 subjects they have been replaced on 16/09/2012 with other 3 subjects following exactly the same protocol.
Now, all are identified as sufficient DNA extraction and had been enrolled into a comprehensive analysis of the gastrointestinal tract microbiota and its contribution on gut homeostasis by using state of the art metagenomics technology.
|
Crohn's Disease
n=34 Participants
46 subjects that exactly meet our inclusion \& exclusion criteria were recruited. Demographic and clinical data were entered for each during the introduction to the study and verifying acceptance to participate. Then after unified bowel preparation protocol, a full Colonoscopy was performed after signing the consent, during which mucosal washing samples were collected from the unified 4 colonic segment sites, as specified in methodology.
Recruitment were completed on 27/05/2012, however, in view of insufficient DNA extraction of 2 subjects they have been replaced on 05/09/2012 with other 2 subjects following exactly the same protocol.
Now, all are identified as sufficient DNA extraction and had been enrolled into a comprehensive analysis of the gastrointestinal tract microbiota and its contribution on gut homeostasis by using state of the art metagenomics technology.
|
Colo Rectal Cancer
n=29 Participants
29 subjects that exactly meet our inclusion \& exclusion criteria were recruited. Demographic and clinical data were entered for each during the introduction to the study and verifying acceptance to participate. Then after unified bowel preparation protocol, a full Colonoscopy was performed after signing the consent, during which mucosal washing samples were collected from the unified 4 colonic segment sites, as specified in methodology.
Recruitment were completed on 28/05/2012, and all have been identified as sufficient DNA extraction.
Now, all are identified as sufficient DNA extraction and had been enrolled into a comprehensive analysis of the gastrointestinal tract microbiota and its contribution on gut homeostasis by using state of the art metagenomics technology.
|
Control: Normal Subjects
n=49 Participants
50 subjects that exactly meet our inclusion \& exclusion criteria were recruited. Demographic and clinical data were entered for each during the introduction to the study and verifying acceptance to participate. Then after unified bowel preparation protocol, a full Colonoscopy was performed after signing the consent, during which mucosal washing samples were collected from the unified 4 colonic segment sites, as specified in methodology.
Recruitment were completed on 22/12/2010, however, in view of insufficient DNA extraction of 6 subjects they have been replaced on 19/09/2012 with other 6 subjects following exactly the same protocol.
Now, all are identified as sufficient DNA extraction and had been enrolled into a comprehensive analysis of the gastrointestinal tract microbiota and its contribution on gut homeostasis by using state of the art metagenomics technology.
|
|---|---|---|---|---|---|
|
Colonic-Mucosa Associated Microbial Species Per Compiled Participants in 5 Different Arms
|
40 microbial species population
Interval 4.0 to 190.0
|
30 microbial species population
Interval 9.0 to 190.0
|
23 microbial species population
Interval 17.0 to 189.0
|
23 microbial species population
Interval 20.0 to 197.0
|
41 microbial species population
Interval 41.0 to 41.0
|
Adverse Events
Irritable Bowel Syndrome
Ulcerative Colitis
Crohn's Disease
Colo Rectal Cancer
Control: Normal Subjects
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place